Zydus Pharmaceuticals (United States)

Statistics

Publications

Citations

456

Authors

Location

Pennington, United States

Zydus Pharmaceuticals (United States) is a company institution in Pennington, United States known for pharmacology, clinical pharmacology, and metabolic liver disease.

Homepage ROR

Top concepts

PharmacologyClinical PharmacologyPharmacyLiver DiseasePharmacotherapyHepatic PharmacotherapyMetabolic Liver DiseaseMedicineLipid MetabolismPharmacodynamics

Publications

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First‐in‐Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose)

Kevinkumar Kansagra, Taufik Momin, Hardik B. Patel et al. · Clinical Pharmacology in Drug Development · 2022 · 73 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis

Mohammad Shadab Siddiqui, Farheen Sheikh, Shiv Kumar Sarin et al. · Clinical Gastroenterology and Hepatology · 2023 · 40 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY‐IL1 in Three Patients with Cryopyrin‐Associated Periodic Syndromes

Pravin Hissaria, Kevinkumar Kansagra, Hardik B. Patel et al. · Clinical Pharmacology in Drug Development · 2023 · 30 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients

Mohammad Shadab Siddiqui, Farheen Shaikh, Mikael Forsgren et al. · Liver Transplantation · 2023 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

1–4 of 23

Authors

AB
Ajay Barot
Zydus Pharmaceuticals (United States), United States
1 publications · 73 citations
1
h-index

1–1 of 1